Javascript must be enabled to continue!
Digoxin-quinidine interaction in patients with chronic renal failure.
View through CrossRef
We evaluated the effect of quinidine on digoxin pharmacokinetic in six patients with severe renal failure. Quinidine reduced the total body clearance of digoxin from 1.87 to 1.06 l/hour (p less than 0.001), and prolonged the digoxin half-life of elimination from 5.20 to 9.61 days (p less than 0.01). The digoxin volume of distribution was unchanged. Renal clearance of digoxin was negligible; thus, the decrease in total body clearance was due to a decrease in the nonrenal clearance of digoxin. The mean trough serum concentrations of quinidine ranged from 1.0 to 3.0 micrograms/ml. We conclude that in patients with chronic renal failure, the dose of digoxin should be decreased by 50% if quinidine therapy is initiated.
Ovid Technologies (Wolters Kluwer Health)
Title: Digoxin-quinidine interaction in patients with chronic renal failure.
Description:
We evaluated the effect of quinidine on digoxin pharmacokinetic in six patients with severe renal failure.
Quinidine reduced the total body clearance of digoxin from 1.
87 to 1.
06 l/hour (p less than 0.
001), and prolonged the digoxin half-life of elimination from 5.
20 to 9.
61 days (p less than 0.
01).
The digoxin volume of distribution was unchanged.
Renal clearance of digoxin was negligible; thus, the decrease in total body clearance was due to a decrease in the nonrenal clearance of digoxin.
The mean trough serum concentrations of quinidine ranged from 1.
0 to 3.
0 micrograms/ml.
We conclude that in patients with chronic renal failure, the dose of digoxin should be decreased by 50% if quinidine therapy is initiated.
Related Results
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Background: Digoxin is extensively prescribed for cardiac diseases, so its chronic or acute toxicity commonly occur. Although digoxin specific antibodies (anti-digoxin Fab) are rec...
Vị trí của digoxin trong điều trị suy tim
Vị trí của digoxin trong điều trị suy tim
Qua phân tích các chứng cứ nêu trên và tham khảo các hướng dẫn điều trị hiện hành, có thể kết luận tóm tắt về việc dùng digoxin điều trị suy tim mạn như tr...
Digoxin: Review of Current Laboratory Practice and Considerations
Digoxin: Review of Current Laboratory Practice and Considerations
Digoxin is a drug used for its effects on the heart, particularly its effect on rate and strength of contraction. Levels are particularly useful in clinical practice owing to its n...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Abnormalities of endothelial function in patients with predialysis renal failure
Abnormalities of endothelial function in patients with predialysis renal failure
BACKGROUND
Endothelial dysfunction plays an important role in the development of atherosclerotic vascular disease, which is the leading cause of mortality in pati...
Study of digoxin use in a public health unit
Study of digoxin use in a public health unit
Digoxin is used for heart failure associated to systolic dysfunction and high ventricular rate. It has a narrow therapeutic range and intoxication may occur due to drug interaction...
Effect of digoxin on circadian blood pressure values in patients with congestive heart failure
Effect of digoxin on circadian blood pressure values in patients with congestive heart failure
BackgroundThe aim of the study was to investigate the effect of chronic digoxin treatment on circadian blood pressure profile in normotensive patients with mild congestive heart fa...

